CoBalT
2013
CBT as Adjunct in Treatment-Resistant Depression
In 469 primary-care patients with antidepressant-resistant depression, 12–18 sessions of CBT added to usual care improved 6-month response and sustained benefit at 46 months compared with usual care alone.
Result
Efficacy: ≥50% BDI reduction at 6 monthsOR 3.26
Below 1 favours usual care alone, above 1 favours 12–18 sessions of CBT added to usual care.
- Absolute difference
- 24 points
The absolute difference is derived from the event rates.
Also reported: Benefit persisted at 46 months (Lancet Psychiatry 2016).
- Subtopic
- Treatment-resistant
- Design
- Multicentre RCT, UK
- Relevance
- Important: one of several pillars.
- Cited in
- NICE NG222 Depression
- Source
- Wiles N, et al. Lancet. 2013;381(9864):375-384.doi 10.1016/S0140-6736(12)61552-9
Discussion & critique
Established CBT as a routine second-line strategy in primary care before further drug switches.